SGFY — Signify Health Share Price
Last trade - 00:00- $6.70bn
- $6.78bn
- $773.40m
- 80
- 10
- 85
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 83.59 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.18 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.55 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -44.18% | ||
| Return on Equity | -58.9% | ||
| Operating Margin | -73.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 337.9 | 501.8 | 610.6 | 773.4 | 901.98 | 1,036.26 | 31.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Signify Health, Inc. is a healthcare platform that uses advanced analytics, technology and nationwide healthcare provider networks to develop payment programs. The Company serves approximately 46 Medicare Advantage health plans ranging from the largest national organizations to smaller regional and provider-owned entities. It also serves a number of healthcare provider organizations ranging from large integrated delivery systems to midsize and small urban and rural entities. The Company operates through two segments. Home & Community Services segment offers a variety of solutions to help manage the health of its customers’ members in their homes. The segment’s solutions include In-home health evaluations and related services, Telehealth through virtual IHEs and Social determinants of health. Episodes of Care Services segment develops provider networks, build software and deliver services that support the organization and financing of healthcare around a patient’s episode of care.
Directors
- Matthew Holt NEC (44)
- Steven Senneff PRE
- Kyle Armbrester CEO
- David Pierre COO
- Laurel Douty EVP (53)
- Josh Builder CTO
- Erin Kelly CCO
- Adam McAnaney GCN (43)
- Peter Boumenot OTH (42)
- Sam Pettijohn OTH
- Marc Rothman OTH (50)
- Kevin McNamara DRC (65)
- Stephen Wiggins DRC (64)
- Taj Clayton IND (44)
- Brandon Hull IND (60)
- Albert Notini IND (63)
- Kyle Peterson IND (35)
- Vivian Riefberg IND (60)
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- October 1st, 2020
- Public Since
- February 11th, 2021
- No. of Employees
- 2,300
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 235,791,331
- Address
- 800 Connecticut Avenue, NORWALK, 06854
- Web
- https://www.signifyhealth.com/
- Phone
- +1 2035414600
- Auditors
- Deloitte & Touche LLP
Similar to SGFY
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners LLC
New York Stock Exchange
Ati Physical Therapy
New York Stock Exchange
FAQ
As of Today at 24:20 UTC, shares in Signify Health are trading at $28.42. This share price information is delayed by 15 minutes.
Shares in Signify Health last closed at $28.42 and the price had moved by +148.86% over the past 365 days. In terms of relative price strength the Signify Health share price has outperformed the S&P500 Index by +170.95% over the past year.
The overall consensus recommendation for Signify Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Signify Health does not currently pay a dividend.
Signify Health does not currently pay a dividend.
Signify Health does not currently pay a dividend.
To buy shares in Signify Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $28.42, shares in Signify Health had a market capitalisation of $6.70bn.
Here are the trading details for Signify Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: SGFY
Based on an overall assessment of its quality, value and momentum Signify Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Signify Health is $29.42. That is 3.52% above the last closing price of $28.42.
Analysts covering Signify Health currently have a consensus Earnings Per Share (EPS) forecast of -$2.78 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Signify Health. Over the past six months, its share price has outperformed the S&P500 Index by +68.06%.
As of the last closing price of $28.42, shares in Signify Health were trading +24.65% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Signify Health PE ratio based on its reported earnings over the past 12 months is 83.59. The shares last closed at $28.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Signify Health's management team is headed by:
- Matthew Holt - NEC
- Steven Senneff - PRE
- Kyle Armbrester - CEO
- David Pierre - COO
- Laurel Douty - EVP
- Josh Builder - CTO
- Erin Kelly - CCO
- Adam McAnaney - GCN
- Peter Boumenot - OTH
- Sam Pettijohn - OTH
- Marc Rothman - OTH
- Kevin McNamara - DRC
- Stephen Wiggins - DRC
- Taj Clayton - IND
- Brandon Hull - IND
- Albert Notini - IND
- Kyle Peterson - IND
- Vivian Riefberg - IND